G Square Capital Closes Single-Asset Continuation Fund for Pharmacy2U

G Square closed a £500M single-asset continuation fund for Pharmacy2U, the UK’s largest digital pharmacy platform, serving more than two million patients and dispensing over 3.5 million items per month. The Continuation Fund was led by Coller Capital alongside a syndicate of institutional investors, with G Square Capital IV, existing shareholders, and management also co-investing.

G Square acquired Pharmacy2U in 2018. Over the course of its 8-year investment, G Square drove significant technology and dispensing automation investments, expanded the Company’s clinical and service offering, and completed and integrated six acquisitions as part of a buy-and-build strategy, resulting in more than 10x growth in both revenue and EBITDA. The new fund will support continued M&A, technology investment, automation, and expansion of clinical services. GroveStreet first became a G Square LP in 2016. Read more here.

Learn more about us or reach out to schedule a meeting.